CCL3L1-CCR5 Genotype and AIDS Risk Assessment
Author Information
Author(s): Hemant Kulkarni, Brian K. Agan, Vincent C. Marconi, Robert J. O'Connell, Jose F. Camargo, Weijing He, Judith Delmar, Kenneth R. Phelps, George Crawford, Robert A. Clark, Matthew J. Dolan, Sunil K. Ahuja
Primary Institution: Veterans Administration Research Center for AIDS and HIV-1 Infection, South Texas Veterans Health Care System, San Antonio, Texas, United States of America
Hypothesis
Can genetic variations in CCL3L1 and CCR5 improve the assessment of AIDS risk in HIV-1-infected individuals?
Conclusion
The combination of laboratory and genetic markers provides a broader assessment of AIDS risk than either marker alone.
Supporting Evidence
- The study found that genetic risk groups (GRGs) based on CCL3L1 and CCR5 variations can predict AIDS risk.
- GRG status provided prognostic information independent of traditional laboratory markers.
- Subjects with high GRG status progressed to AIDS more rapidly than those with low GRG status.
- The combination of genetic and laboratory markers improved risk assessment for AIDS.
Takeaway
Scientists found that looking at both genes and lab tests can help doctors better understand how likely someone is to get AIDS.
Methodology
A prospective, single-site cohort study of 1,132 HIV-positive subjects was conducted to assess AIDS risk using genetic and laboratory markers.
Potential Biases
Potential biases may arise from the cohort's specific demographic and clinical characteristics.
Limitations
The study was conducted at a single site and may not be generalizable to all populations.
Participant Demographics
The cohort included an ethnically mixed group of HIV-positive individuals.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website